BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 5527163)

  • 21. Neuroleptics as a guideline to biological research in psychotic disorders.
    van Praag HM
    Compr Psychiatry; 1975; 16(1):7-22. PubMed ID: 1089049
    [No Abstract]   [Full Text] [Related]  

  • 22. The neuroleptics. 4. Toxicity and side effects in man and in the laboratory animal.
    Degkwitz R; Heushgem C; Hollister LE; Jacob J; Julou L; Lambert PA; Marsboom R; Meier-Ruge W; Schaper WK; Tuchmann-Duplessis HC
    Mod Probl Pharmacopsychiatry; 1970; 5():71-84. PubMed ID: 5527173
    [No Abstract]   [Full Text] [Related]  

  • 23. [Use of modern psychotropic drugs by the non-psychiatrist].
    Fleischhauer J
    Internist (Berl); 1972 May; 13(5):179-86. PubMed ID: 4403070
    [No Abstract]   [Full Text] [Related]  

  • 24. The distribution of the butyrophenones haloperidol, trifluperidol, moperone, and clofluperol in rats, and its relationship with their neuroleptic activity.
    Janssen PA; Allewijn FT
    Arzneimittelforschung; 1969 Feb; 19(2):199-208. PubMed ID: 5818759
    [No Abstract]   [Full Text] [Related]  

  • 25. [Long-acting neuroleptics. 5 years of observations].
    Dencker SJ
    Lakartidningen; 1972 Mar; 69():85-8. PubMed ID: 4664129
    [No Abstract]   [Full Text] [Related]  

  • 26. Proceedings: Differentiation between neuroleptic antipsychotic properties and side effects by subgroups of dopaminergic neurons.
    Bunney BS; Aghajanian GK
    Psychopharmacol Bull; 1974 Oct; 10(4):17-8. PubMed ID: 4473793
    [No Abstract]   [Full Text] [Related]  

  • 27. [Neurotropic properties of fluphenazine].
    Liubimov BI; Raevskiĭ KS; Ostrovskaia RU; Barkov NK; Krolevets GN
    Farmakol Toksikol; 1971; 34(3):287-90. PubMed ID: 5106035
    [No Abstract]   [Full Text] [Related]  

  • 28. [Stereotypy following amphetamine and apomorphine and its influencing by drugs].
    Menge HG; Brand U
    Psychopharmacologia; 1971; 21(3):212-28. PubMed ID: 5095412
    [No Abstract]   [Full Text] [Related]  

  • 29. Maintenance therapy of chronic psychostic patients with a weekly oral dose of R 16 341. A controlled double-blind study.
    Baro F; Brugmans J; Dom R; Van Lommel R
    J Clin Pharmacol J New Drugs; 1970; 10(5):330-41. PubMed ID: 4917354
    [No Abstract]   [Full Text] [Related]  

  • 30. [A practical guide for the use of psychopharmacologic agents. II. Antipsychotic and antiparkinson agents].
    Chouinard G
    Union Med Can; 1976 Sep; 105(9):1387-97. PubMed ID: 9720
    [No Abstract]   [Full Text] [Related]  

  • 31. Rational use of psychotropic drugs. III. Major tranquilizers.
    Greenblatt DJ; Shader RI
    Am J Hosp Pharm; 1974 Dec; 31(12):1226-31. PubMed ID: 4156455
    [No Abstract]   [Full Text] [Related]  

  • 32. The many faces of akathisia.
    Van Putten T
    Compr Psychiatry; 1975; 16(1):43-7. PubMed ID: 234073
    [No Abstract]   [Full Text] [Related]  

  • 33. Our experience with octoclothepine therapy.
    Klíma V; Koutská M; Koutský J
    Act Nerv Super (Praha); 1972; 14(2):89-90. PubMed ID: 5040175
    [No Abstract]   [Full Text] [Related]  

  • 34. Testing of computer-assisted methods for classification of pharmacological activity.
    Perrin CL
    Science; 1974 Feb; 183(4124):551-2. PubMed ID: 4809568
    [No Abstract]   [Full Text] [Related]  

  • 35. On stereotypy and catalepsy: studies on the effect of amphetamines and neuroleptics in rats.
    Fog R
    Acta Neurol Scand Suppl; 1972; 50():3-66. PubMed ID: 4565013
    [No Abstract]   [Full Text] [Related]  

  • 36. Considerations for the pre-clinical evaluation of new psychiatric drugs: a case study with phenothiazine-like tranquilizers.
    Irwin S
    Psychopharmacologia; 1966; 9(4):259-87. PubMed ID: 6011791
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pharmacological properties of the new neuroleptic of the phenothiazine series--dixyrazine].
    Mikhaĭlova TV; Terekhina AI; Gilev AP
    Farmakol Toksikol; 1969; 32(1):28-31. PubMed ID: 4388895
    [No Abstract]   [Full Text] [Related]  

  • 38. Implications of amphetamine-induced stereotyped behavior as a model for tardive dyskinesias.
    Rubovits R; Klawans HL
    Arch Gen Psychiatry; 1972 Oct; 27(4):502-7. PubMed ID: 5072718
    [No Abstract]   [Full Text] [Related]  

  • 39. Neuroleptics: relation between cataleptic and anti-turning actions, and role of the cholinergic system.
    Muller P; Seeman P
    J Pharm Pharmacol; 1974 Dec; 26(12):981-4. PubMed ID: 4156868
    [No Abstract]   [Full Text] [Related]  

  • 40. Pathophysiology of schizophrenia and the striatum.
    Klawans HL; Goetz C; Westheimer R
    Dis Nerv Syst; 1972 Nov; 33(11):711-9. PubMed ID: 4266033
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.